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Unusual fragmentation was observed for doubly charged VPDPR in which cleavage C-
terminal to proline and N-terminal to aspartic acid yielded b2 ( a2)/y3 complementary ions.
This unique fragmentation is contradictory to trends previously established by statistical
analysis of peptide tandem mass (MS/MS) spectra [1– 4]. Substitution of alanine for aspartic
acid (i.e., VPAPR) did not change the fragmentation, indicating the cleavage was not directed
by aspartic acid. Fragmentation patterns for VPAPR and V(NmA)APR (NmA  N-methyl
alanine) were compared to determine whether conformational constraints from proline’s cyclic
side-chain contribute to b2 ion formation. While both peptide sequences fragmented to yield
b2/y3 ions, only VPAPR produced a2 ions, suggesting the VP b2 ion is structurally different
from the V(NmA) b2 ion. Instead, the V(NmA) b2 ion was accompanied by an ion correspond-
ing to formal loss of 71. The suspected structural differences were confirmed by isolation and
fragmentation of the respective b2 ions (i.e., MS
3 spectra). Evidence supporting a diketopipera-
zine structure for the VP b2 ion is reported. Fragmentation patterns for the VP b2 ion and a
synthetic VP diketopiperazine showed great similarity. N-terminal acetylation of VPAPR
prevented the formation of the VP b2 ion, presumably by blocking nucleophilic attack by the
N-terminal amine on the carbonyl oxygen of the protonation site. Acetylation of the
N-terminus for V(NmA)APR did not prevent the formation of the V(NmA) b2 ion, indicating
the V(NmA) b2 ion has a structure, presumably that of an oxazolone, which requires no attack
by the N-terminus for formation. Finally, high-resolution, accurate mass measurements
determined that the V(NmA) (b2  71) ion results from losing a portion of valine from
oxazolone V(NmA) b2 ion, rather than cross-ring cleavage of the alternate
diketopiperazine. (J Am Soc Mass Spectrom 2006, 17, 20–28) © 2005 American Society for
Mass SpectrometryMass spectrometry is playing a key role, inconjunction with other analytical tools (e.g.,electrophoretic and multidimensional separa-
tions and sequence database searching algorithms), to
elucidate gene function from protein expression profiles
[5–9]. Peptide sequence information is obtained by
using tandem mass spectrometry (MS/MS) and low-
energy collision induced dissociation (CID) to identify
individual proteins. Useful algorithms like SEQUEST
[10] and Mascot [11] have been developed to identify
proteins by matching raw MS/MS CID spectra with
peptide sequences from protein or translated nucleotide
sequence databases. The predictive model of peptide
fragmentation used by most current automated peptide
sequencing algorithms anticipates cleavage of all amide
bonds along the peptide backbone, presumably result-
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doi:10.1016/j.jasms.2005.06.016ing in the formation of bn and yn ions, using Roepstorff/
Biemann nomenclature [12, 13]. Other ion types are also
formed that can be useful in automated peptide se-
quencing, including an ions, immonium ions, internal
sequence ions, and neutral losses of ammonia and
water from these ions. Differences between the m/z
values of adjacent fragment ions of the same series can
be correlated to the mass of an amino acid residue.
Thus, a complete series of either of these ion types
allows the sequencing of the entire fragmented peptide.
Predicting spectral content using this model for peptide
fragmentation has been proven successful on a funda-
mental level where automated protein identification
can be achieved for many samples using database
searching algorithms [14 –20]. However, this simple
model of peptide fragmentation occasionally fails to
correctly predict the appearance of peptide MS/MS
spectra, resulting in poor protein matches using data-
base searching algorithms [21]. Attempts to understand
the limitations of these algorithms and improve the
fragmentation model are being made. Some recent
strategies involve statistical analysis of fragmentation
patterns of peptide MS/MS spectra [1– 4, 22] and study-
ing the chemistry involved in peptide fragmentation
mechanisms [23–32] to more intelligently predict
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proaches, residue specific enhanced cleavages have
been identified and investigated for peptides containing
either proline or aspartic acid residues [1, 22, 26, 33–35].
Peptides containing either of these residues often pro-
duce incomplete ion series in the spectra, preventing
sequencing of the entire peptide. Instead, preferential
cleavage of the peptide bond occurs immediately N-
terminal to proline and C-terminal to aspartic acid
residues, particularly when the number of basic resi-
dues (e.g., arginine, lysine, and histidine) in the se-
quence is greater than the number of ionizing protons,
producing a few dominant fragment peaks in the spec-
tra. Contrary to these residue specific trends, fragmen-
tation of a pentapeptide (VPDPR in single letter abbre-
viations for amino acid residues) with proline and
aspartic acid in the second and third residue positions,
respectively, results in a MS/MS spectrum showing
cleavage at the second peptide bond, C-terminal to
proline and N-terminal to aspartic acid. While formation
of a b2/y3 ion pair from a pentapeptide is not unusual,
cleavage C-terminal to a proline residue is interesting.
Based on current knowledge of peptide fragmentation
trends for larger peptides (5 residues) where proline
is located at an internal sequence position other than the
first or second residue positions, one might expect
cleavage N-terminal to proline yielding formation of
abundant y4 and y2 ions for VPDPR with little other
sequencing information present in the spectrum. Fur-
ther, yn ions are expected rather than bn ions because
arginine’s basic side-chain would encourage charge
retention on the C-terminal portion of the peptide
fragment. However, the observation that cleavage C-
terminal to proline can and does occur when proline is
Scheme 1. Mechanism of peptide fragmentation to yield a pro-
tonated oxazolone b2 ion and the corresponding a2 ion from a
doubly protonated precursor ion.the second residue in the peptide sequence has beennoted on a larger scale in the statistical analysis of 5500
unique peptide MS/MS spectra as previously reported
by Kapp et al. [2]. The primary objective of this research
focuses on understanding gas-phase ion structure when
proline is the C-terminal residue of a b2 ion and the
relative stabilities of such structures following forma-
tion.
The most common bn ion structure (where n  2) is
that of a protonated oxazolone [24, 36 – 40]. The forma-
tion of this ion type from a doubly protonated precursor
ion proceeds through a mechanistic pathway involving
charge-directed peptide fragmentation as illustrated in
Scheme 1 [36, 37, 41– 43]. Scheme 1 is shown with the
protonation site on the nitrogen in the peptide bond for
simplicity, yet protonation of the carbonyl oxygen may
actually be involved. The lone pair of electrons, present
in the carbonyl oxygen of the adjacent carbonyl N-
terminal to the site of protonation, attacks the elec-
tropositive carbonyl carbon at the protonation site. This
initiates dissociation of the protonated peptide bond
and rearrangement results in the formation of a cyclic
protonated oxazolone (or bn ion) and the singly charged
remaining portion of the peptide (yn ion). Protonated
oxazolone structures may undergo ring opening to
form an acylium bn ion structure. It is from this acylium
ion that bn ions may lose carbon monoxide to form
corresponding an ions. In fact, it has been reported [44]
that the presence of a bn/an ion pair is often indicative
of a protonated oxazolone structure for the correspond-
ing bn ion.
The free amine moiety located on the N-terminus of
the peptide may initiate the formation of b2 ions pos-
sessing a diketopiperazine structure [21, 40, 45] rather
than the more common protonated oxazolone structure
of larger bn fragments. The mechanism of diketopipera-
zine formation is shown in Scheme 2 and is essentially
the same as that of protonated oxazolone formation.
The main difference is that the lone pair of electrons on
the N-terminal amino-nitrogen, rather than the elec-
trons on the adjacent carbonyl oxygen, is the initiator of
attack on the carbonyl carbon at the protonation site.
The final b2 ion structure is that of a protonated,
Scheme 2. Mechanism of formation of diketopiperazine b ion2
and a y1 ion from a doubly protonated precursor ion.
22 SMITH ET AL. J Am Soc Mass Spectrom 2006, 17, 20–28six-membered cyclic diketopiperazine rather than a
five-membered oxazolone.
Previously established fragmentation trends for pep-
tides containing proline fail to predict the formation of
a predominant VP b2 ion from collision induced disso-
ciation of doubly charged VPDPR in a quadrupole ion
trap. It has been speculated that an alternative b2 ion
structure, specifically a diketopiperazine rather than an
oxazolone, may be formed. Farrugia et al. reported MS3
experiments that revealed the b2 ion derived from either
HG-Y or GH-Y (using single letter amino acid abbrevi-
ations) yielded identical spectra to the MS/MS spec-
trum of the protonated diketopiperazine of GH [46].
Furthermore, the side-chain protonated diketopipera-
zine of GH was thermodynamically favored over all
other b2 isomeric structures using ab initio calculations.
Figure 1. CID-LCQ spectra of doubly charged (a) VPDPR, (b)
VPAPR, and (c) V(NmA)APR; im-X indicates an immonium for a
given amino acid residue.Additionally, Goolcharran and Borchardt reported thekinetic analysis of the conversion of FP-p-nitroaniline to
FP-diketopiperazine in solution [47]. Among other so-
lution phase properties that affected the rate of cycliza-
tion to a diketopiperazine structure (i.e., pH, tempera-
ture, buffer concentration, and buffer species), the
identity of the N-terminal amino acid residue played a
major role in the kinetics. Specifically, the rate constant
for degradation of Val-Pro-p-nitroaniline to Val-
Pro-diketopiperazine was 116 M1 hr1, the second
lowest rate constant of the residues investigated. The
primary objective of the work presented here is to
provide evidence for the stable gas-phase structure of a
b2 ion containing proline as the C-terminal residue.
Materials and Methods
Chemicals and Reagents
All solvents used in peptide synthesis were purchased
from Sigma-Aldrich (St. Louis, MO). NovaSyn amino
acid residues and Wang resin beads were purchased
from EMD Biosciences (San Diego, CA). Lyophilized
VPDPR and acetic anhydride (to acetylate the N-terminus
of the peptide sequence was purchased from Sigma (St.
Louis). Cyclo-PV, a synthetic version of the dike-
topiperazine VP b2 ion (see inset for Figure 2c), was
purchased from BACHEM (Bubendorf, Switzerland).
Peptide Synthesis and Chemical Modifications
Solid-phase peptide synthesis was performed to synthe-
size VPAPR and V(NmA)APR (NmA is an abbreviation
for N-methylalanine) using 9-fluorenylmethyloxycar-
bonyl (FMOC)-based chemistry. The C-terminal residue
for both peptides was arginine and the synthesis was
initiated from Wang resin beads to which PMC (2,2,5,7,8-
pentamethyl-chroman-6-sulphonyl)-protected arginine
was coupled at a loading capacity of 0.54 mmol g1. The
resin was allowed to swell for 30 min in dimethyl form-
amide (DMF)/dichloromethane (DCM) (50:50) mixture
before synthesis. Washing, deprotection with piperidine,
and residue-coupling steps were completed for the C-
terminal proline and alanine residues. The resin beads
were then air-dried and divided equally to continue
synthesis in two separate procedures, one involving the
coupling of proline and finally valine and the second
involving coupling of N-methyl alanine, followed by
valine. After the synthesis was completed, a final depro-
tection step was performed (to form a free N-terminus)
and cleavage of the synthesized peptide from the Wang
resin beads was accomplished with a cleavage mixture of
95% trifluoroacetic acid with 2.5% (vol/vol) anisole
added. The cleaved peptide (in solution) was separated
from the solid resin beads by vacuum filtration, precipi-
tated in 50 mL cold diethyl ether and furthered recovered
through gravity filtration.
Acetylation of the free amine moiety at the N-terminus
of each synthesized peptide was achieved by adding 5%
(vol/vol) acetic anhydride in DMF to the peptide-resin
23J Am Soc Mass Spectrom 2006, 17, 20–28 STRUCTURE OF PROLINE-CONTAINING b2 IONbeads following a final deprotection step (prior to the final
cleavage from resin beads). Because the side chains of the
residues were still protected by t-butyl groups, there was
no acetylation to arginine residues.
Instrumentation
Low-energy collision induced dissociation experiments
Figure 2. CID-LCQ MS/MS/MS spectra of b2 ions originating
from doubly charged (a) VPAPR (m/z 197.0), (b) V/NmA/APR
(m/z 184.9), and (c) singly charged cyclo(-PV) (m/z 197.0); im-X
indicates an immonium for a given amino acid residue.were performed in a quadrupole ion trap (Thermofinni-gan LCQ Classic, San Jose, CA) with parameters set for
positive ion detection. Electrospray ionization (ESI)
conditions included a needle voltage of 4.5 kV, nitrogen
sheath gas flow rate of 8 L/min, a capillary voltage
of 10 V with a constant capillary temperature of
200 °C. The lyophilized peptide was dissolved in 50%
aqueous methanol with 1% acetic acid to yield a 10–30
M solution. The peptide solution was directly infused
into the LCQ using a syringe pump at a rate of 2–3
L/min. In the CID experiments, the incident ion
energy was typically varied from 20 to 35% relative
collision energy, as defined by Xcalibur software con-
trolling the LCQ data acquisition.
High-resolution measurements were performed with
an IonSpec 4.7 tesla Fourier transform ion cyclotron
resonance (FT-ICR) mass spectrometer (Lake Forest,
CA) equipped with an Analytica electrospray ionization
(ESI) source (Branford, CT). The ions were introduced
into the instrument by infusing 10–30 M solutions of
the peptides in 50:50 methanol:water with 1% acetic
acid using a stainless steel microelectrospray needle
(0.004 in. i.d.) at a flow of 2–3 L/min. The source
temperature was set at 200 °C, and 3.8 kV was applied
to the ESI needle. The instrument has two regions of
differential cryogenic pumping, referred to as the
source and analyzer regions, with a typical analyzer
base pressure of 7  1011 torr. The electrosprayed
ions passed through a skimmer and were collected in
an external RF-only hexapole, where they were al-
lowed to accumulate for 400 ms before passing into
the analyzer through a shutter. To perform fragmen-
tation experiments, the desired ion was trapped in-
side the ICR cell by ejecting all other mass-to-charge
values via a frequency sweep. Simultaneously apply-
ing a SORI pulse with a nitrogen gas pulse frag-
mented the isolated ion. Typical SORI conditions
included a 2–3 s pulse with 1–3 V amplitude at an
offset of 1000 Hz.
Results and Discussion
Collision induced dissociation of doubly charged
VPDPR in a quadrupole ion trap (ThermoFinnigan LCQ
Classic) produced a MS/MS spectrum showing cleav-
age at the second peptide bond, C-terminal to proline
and N-terminal to aspartic acid (see Figure 1a). This
fragmentation pattern contradicts expected residue spe-
cific behavior as determined by statistical analysis of
fragmentation patterns for peptide MS/MS spectra for
both proline and aspartic acid residues. While the
predominant fragment ions present in the resulting
CID-LCQ spectrum (see Figure 1a) are singly and
doubly charged y4 ions and a b3/y2 ion pair and follow
expectations for proline-induced cleavages, there are
other interesting peaks present in the spectrum that
would not typically be predicted. In reality, the b2 (
a2)/y3 complementary ions that are present with signif-
icant relative intensities in the MS/MS spectrum would
24 SMITH ET AL. J Am Soc Mass Spectrom 2006, 17, 20–28not be expected based on fragmentation trends ob-
served for larger peptides (5 residues) because these
ions result from cleavage C-terminal to proline and
cleavage N-terminal to aspartic acid. However, the
fragmentation pattern of doubly charged VPAPR
(where aspartic acid is replaced by alanine) shows
slightly enhanced formations of these same fragments,
b2 ( a2)/y3 ions (see Figure 1b). It is concluded that the
formation of these ions is not initiated by the presence
of aspartic acid adjacent to proline in this peptide
sequence. Formation of b2 ( a2)/y3 ions by fragmen-
tation of VPAPR and b2 ( a2)/y3 ions by VPDPR are
common to pentapeptides of the general sequence
Figure 3. MS/MS of doubly charged N-acetylat
239.9 indicates the free amino-terminus in VPAP
Scheme 3. Chemical structures of neutral N-methyl alanine and
proline.ion.XXXXR, yet the presence of proline as the C-terminal
residue in the resulting b2 ion is interesting. To under-
stand the role proline plays in the formation of the b2 (
a2)/y3 complementary ions from CID of doubly
charged VPAPR, the structural constraints that are
unique to proline were omitted from the precursor ion
by substituting N-methyl alanine in the second se-
quence position (see Scheme 3) N-methyl alanine
(NmA) contains a tertiary nitrogen that mimics the
basicity of the proline residue, yet the side-chain is not
chemically bound to the peptide backbone, allowing a
wider range of rotation about the single bonds in the
residue and eases overall rotation of the peptide back-
bone.
MS/MS spectra obtained with CID in a quadrupole
ion trap instrument are shown in Figure 1b and c for
doubly charged VPAPR and V(NmA)APR, respec-
tively. The most striking differences between the frag-
mentation patterns of the two peptide ions include the
absence of doubly charged y4 ion and the prevalence of
b2/y3 complementary ions in the V(NmA)APR spec-
trum. The absence of (y4)
2 ion and the decreased
intensity of y4 ion in V(NmA)APR spectrum can be
explained by the absence of the proline residue in the
PAPR acquired by CID-LCQ. The absence of m/z
nvolved in the formation of the VP b fragmented V
R is i 2
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in this position to direct cleavage to the VOP peptide
bond, fragment ions from this dissociation are no longer
dominant. It should be noted that Vaisar and Urban
have previously reported mono-N-methylated residues
located internally in the peptide sequence may exhibit
N-terminal preferential cleavage under low-energy col-
lision induced dissociation conditions [41]. Despite this
fact, cleavage occurring at the second peptide bond in
doubly charged V(NmA)APR becomes the most prom-
inent dissociation pathway, forming the b2/y3 comple-
mentary ions. Another interesting feature of the two
spectra is the presence of different low mass ions. For
VPAPR, the b2 ion is paired with the formation of an a2
ion (formal loss of 28 u from b2) while the V(NmA)APR
spectrum shows a peak with a m/z value equivalent to a
formal loss of 71 u from the b2 ion. Through an MS
3
experiment in which the b2 ion formed from fragmen-
tation of the corresponding doubly charged precursor
ion is isolated and further fragmented, the structural
characteristics of the b2 ion may be determined. The
fragmentation patterns of the respective b2 ions in such
an experiment [i.e., VP b2 (m/z 197.0) and V(NmA) b2
(m/z 184.9)] were measured and are shown in Figure 2a
and b, respectively. From the MS3 spectra, it can be
concluded that the b2  71 ion in the V(NmA)APR
MS/MS spectrum and the a2 ion in the VPAPR MS/MS
spectrum do originate from the respective b2 ions rather
than larger bn ions or the precursor ions.
The VP b2 ion fragments to form not only the
corresponding a2 ion, but also the immonium ions for
proline (m/z 70) and valine (m/z 72). While it is not
possible for the V(NmA) b2 ion to produce the immo-
nium ion for proline (no proline in the sequence), there
is also no formation of the valine immonium ion. It can
be concluded from the vast differences in the resulting
fragmentation patterns for each b2 ion that the V(NmA)
b2 ion does not have the same gas-phase ion structure as
the VP b2 ion that is formed as a result of charge-
directed dissociation of the initial protonated peptide
ions [doubly charged V(NmA)APR and VPAPR, respec-
tively].
In peptides where proline is located within 1 to 2
residues of the N-terminus, involvement of the N-
terminal free amine in cleavage C-terminal to proline
may allow the formation of fragment ions that would
not be predicted by the usual fragmentation patterns of
proline-containing peptides (i.e., the observed b2 (
a2)/y3 ions from doubly charged VPDPR and VPAPR in
Figure 1a and b). The involvement of the N-terminal
amine in formation of the b2 ion would lead one to
suspect the resulting gas-phase ion structure for the b2
ion is a diketopiperazine. However, formation of the a2
ion from dissociation of the corresponding b2 ion, as
observed in the fragmentation of VP b2 ion, has been
considered indicative of a protonated oxazolone struc-
ture that requires no participation of the free N-termi-
nus for its formation [44]. It remains necessary to
perform additional experiments to determine whether aVP diketopiperazine can fragment to lose CO and form
an a2 ion.
Evidence for Diketopiperazine VP b2
Fragmentation of synthetic diketopiperazine VP b2. One of
the classic methods to determine proposed gas-phase
ion structures is to fragment a synthetic compound that
was chosen to have the same structure as the suspected
structure. A comparison of the fragmentation patterns
for the synthetic compound, assuming its structure does
not change significantly upon ionization, and the ion in
question will reveal similarities or differences in the two
structures. As shown in Figure 2a and c, the fragmen-
tation patterns for the VP b2 ion formed initially by
fragmentation of doubly charged VPAPR and for singly
charged cyclo-PV are similar. The dominant fragmen-
tation pathway involves the loss of carbon monoxide
for both ions, resulting in a2 ion as the base peak in the
VP b2 MS
3 spectrum (Figure 2a) and MH  CO as the
base peak in the cyclo-PV MS/MS spectrum (Figure 2c).
Even more subtle features of the two spectra are iden-
tical: immonium ions are formed for both residues,
proline and valine (m/z 70 and 72) and peaks are present
at m/z values of 141, 152, and 180, corresponding to
sequential losses of water and ammonia (appropriate
labels are provided in Figure 2c). It should be noted that
there are minor differences between the two spectra.
For example, singly charged, synthetic diketopipera-
zine VP produces a minor peak at m/z 152 that is absent
from the MS3 spectrum for VP b2 ion. Other differences
between the pairs of spectra are the relative peak
intensities for the immonium ions, loss of ammonia
from the precursor ion (m/z 180), and the loss equivalent
to two CO molecules (m/z 141).
The residual internal energy of the precursor ions
resulting from ionization for cyclo( PV) and from
previous CID activation for the VP b2 ion may contrib-
ute to these spectral differences. Additionally, there are
likely to be differences in the precursor ion populations
based on the presence of multiple protonation sites and
the methods by which the precursor ions were formed
(i.e., electrospray ionization from an acidified methan-
olic solution versus ion formation by collision induced
dissociation of another ion). However, the high degree
of similarity in the fragmentation patterns for a syn-
thetic diketopiperazine VP ion and the VP b2 ion
provides further evidence the VP b2 ion does have a
gas-phase diketopiperazine structure.
N-terminal acetylation of VPAPR. As previously de-
scribed, the N-terminal moiety must be a free amine to
initiate formation of a diketopiperazine b2 ion structure.
By chemically modifying the free amino terminus with
acetylation (resulting in CH3(CO)NH. . .as the N-terminal
functional group), the formation of a diketopiperazine
b2 ion structure can be prevented. The formation of a
protonated oxazolone b2 ion (originating from nucleo-
philic attack of the protonated carbonyl carbon by the
26 SMITH ET AL. J Am Soc Mass Spectrom 2006, 17, 20–28adjacent N-terminal carbonyl oxygen) would not be
prevented by this chemical modification to the peptide
sequence.
The MS/MS spectrum for doubly charged acety-
lated-VPAPR is given in Figure 3. The b2 ion is expected
to occur at m/z 239.9; the inset spectrum shows a
magnified version of the MS/MS spectrum from m/z
215 to 250. No ion peaks at m/z 239.9 that are signifi-
cantly higher than the spectral noise were detected.
Absence of a b2 ion when the N-terminus is blocked is
consistent with involvement of the free amine of the
peptide N-terminus in the formation of the VP b2 ion. It
can be concluded that the correct structure for this ion is
a diketopiperazine or other ion formed by the involve-
ment of the free N-terminus.
Evidence for Oxazolone V(NmA) b2
N-terminal acetylation of V(NmA)APR. Chemical modi-
fication of the N-terminus of the (NmA)-containing
peptide sequence by acetylation should not affect the
propensity of this precursor ion to fragment to form a b2
ion if that ion is produced through the protonated
oxazolone dissociation pathway. Recall that the forma-
tion of an oxazolone structure required attack of the
adjacent N-terminal carbonyl oxygen lone pair elec-
trons on the electropositive carbonyl carbon at the site
of protonation (see Scheme 1). If the V(NmA) b2 ion is
an oxazolone, modification of the free amine on the
N-terminus should have little or no affect on the forma-
tion of oxazolone bn ions and therefore, not prevent the
formation of the V(NmA) b2 ion from the acetylated
V(NmA)APR precursor ion.
Figure 4 shows the MS/MS spectrum from CID
activation in the LCQ instrument for singly charged
acetylated V(NmA)APR. There is a strong b2 ion peak
Figure 4. MS/MS of singly charged N-acetylated V/NmA/APR
acquired by CID-LCQ. The presence of m/z 227.4 indicates the free
amino-terminus in V/NmA/APR is not involved in the formation
of the V(NmA) b2 fragment ion.present at m/z 227.4, indicating that the acetylatedN-terminal amine is not involved in the formation of
this b2 ion. Unfortunately, the low mass cutoff inherent
in CID-LCQ spectra prevented the measurement of the
corresponding b2  71 ion. There is no way to deter-
mine if the N-terminal modification affected the forma-
tion of this ion from the CID-LCQ data. The identity of
the b2  71 ion is ambiguous with the level of mass
accuracy that can be obtained with CID-LCQ data.
Ideally, fragmentation of the doubly charged V(N-
mA)APR precursor ion (rather than the singly charged
ion) should have been used to evaluate the involvement
of the N-terminal amine in the formation of the
V(NmA) b2 ion. Unfortunately, chemical alteration of
the second most basic site on the pentapeptide (i.e., the
N-terminal amine) significantly reduced the signal of
the doubly charged ion to the point that only very poor
quality MS/MS spectra (low signal-to-noise) could be
acquired. Although a second proton is absent from the
acetylated precursor ion, it is assumed that this proton
is not critical to formation of the V(NmA) b3 ion from
the acetylated precursor ion because a larger b2 ion is
produced. Results from this experiment provide strong
evidence that the V(NmA) b2 ion is an oxazolone.
Identification of V(NmA) b2 71 ion. There are two
possible pathways by which the V(NmA) b2 ion could
formally lose a mass equivalent to 71 u, each of which
originates from either the diketopiperazine or proton-
ated oxazolone V(NmA) b2 ion structures. Two possible
product ions with m/z values equivalent to b2  71 are
shown in Scheme 4 and cannot be distinguished from
one another at the level of mass accuracy available in
CID-LCQ data (0.5 u). Fortunately, the b2  71 ions
possible from each b2 structure have unique elemental
compositions, providing a mass difference (0.0364 u)
that can be distinguished with high-resolution and
mass accuracy measurements in a Fourier-transform
mass spectrometer (FTMS). Figure 5 shows the MS/MS
spectrum resulting from sustained off resonance irradi-
ation-CID (SORI-CID) of singly charged V(NmA)APR
measured with high mass accuracy and resolution. The
poor signal intensity for doubly charged V(NmA)APR,
again, prevented the use of the doubly charged precur-
sor ion for SORI-CID measurements and it was as-
sumed that the structural identity of the resulting b2 
71 ion was the same, regardless of the charge state of the
Scheme 4. Possible b 71 ions resulting from either (a) the2
diketopiperazine b2 ion or (b) the oxazolone b2 ion.
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of singly charged V(NmA)APR, has an accurate mass of
114.0553 u when the MS/MS spectrum is internally
calibrated using the immonium ion from arginine atm/z
112.0900. This measured mass is closest to that of the b2
 71 ion arising from loss of a portion of the valine
side-chain from the oxazolone V(NmA) b2 ion structure
and is inconsistent with cross ring cleavage of the
diketopiperazine structure (see inset for Figure 5), indi-
rectly providing further evidence that the V(NmA) b2
ion is an oxazolone.
The V(NmA) b2 ion is an atypical oxazolone in that a
corresponding a2 ion is not formed, but an ion equiva-
lent to a formal loss of 71 u from the b2 ion is formed
instead. The V(NmA) b2 ion is likely a methylated
oxazolone, rather than the more common protonated
oxazolone as shown in Scheme 1. The presence of the
fixed charge (as a methyl group) and the absence of the
proton on the ring nitrogen prevent intramolecular
proton migration. The subsequent b2  71 ion may be
thought of as complementary to an a1 ion, which would
otherwise form.
Conclusions
The loss of CO, forming the corresponding a2 ion, has
been considered a marker for a protonated oxazolone b2
ion. Experimental evidence, including chemical modifi-
Figure 5. High-resolution measurements of b2
singly charged VNmAAPR. Measured fragment
the valine residue from an oxazolone b ion r2
diketopiperazine b2 ion; im-X indicates an immoniumcation of the N-terminus of the peptide and comparison
of fragmentation patterns for the b2 ion and a corre-
sponding synthetic diketopiperazine, supports the sug-
gestion that the VP b2 ion is a diketopiperazine even
though formation of the a2 ion is observed.
These results also directly support previous work by
Eckart and coworkers in which a GP b2 ion was
determined to have a gas-phase structure different from
the typical protonated oxazolone [48]. The overall sta-
bility of the VP b2 diketopiperazine ion may encourage
its formation if the transition-state structure is close to
that of the product diketopiperazine structure [46].
O’Hair and coworkers suggested a side-chain protona-
tion site on the histidine residue for a GH b2 dike-
topiperazine ion stabilized the diketopiperazine struc-
ture. While VP b2 has no such side-chain that would
encourage charge retention (valine provides only a
branched alkyl moiety), the overall stability of a 5,
6-membered bicyclic structure may encourage the for-
mation of the diketopiperazine structure. Further sta-
bility calculations are needed to provide further evi-
dence either for or against this speculation.
The larger impact of this work on automated se-
quencing relies on the refinement of the fragmentation
trends observed for proline-containing peptide se-
quences in which enhanced cleavage N-terminal to
proline residues is expected. The cleavage C-terminal to
fragment ion from SORI-CID/RE spectrum of
/z value matches that of the loss of a portion of
r than the cross-ring cleavage of the isomeric71
ion m
athefor a given amino acid residue.
28 SMITH ET AL. J Am Soc Mass Spectrom 2006, 17, 20–28proline can and does occur in bioactive peptides as
demonstrated by the presented research.
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